However, in mice with CKD-MBD, activin receptor type II A inhibition by the ligand trap RAP011 prevented development of renal osteodystrophy, that is, there was correction of high bone turnover and improvement of osteoblastic function [14]. Here, ACVR2A is linked to renal osteodystrophy.